Reviews the clinical features and management pitfalls of cocaine-associated agitated delirium to help clinicians avoid misdiagnosis and litigation.
Alerts clinicians to misdiagnosis risks in cocaine-associated agitated delirium; leaves open need for prospective validation of management strategies.
The incidence of this previously rare disorder, cocaine-associated agitated delirium, appears to have increased drastically within the last 18 months. The underlying neurochemical abnormalities have recently been characterized, but most clinicians have had little experience with management of agitated delirium. The basic clinical and pathological features of this disorder are reviewed, and common pitfalls in diagnosis and management that frequently lead to needless but very expensive litigation are discussed.
No takes yet. Share an insight, caveat, or question.
Wetli et al. (1996) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: